 Douglas Adams
Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Unfolded Protein Response | 2 | 2026 | 60 | 0.830 |
Why?
| | Osteoblasts | 12 | 2026 | 145 | 0.800 |
Why?
| | Bone and Bones | 12 | 2026 | 314 | 0.790 |
Why?
| | Osteoporosis | 4 | 2018 | 236 | 0.620 |
Why?
| | Proteome | 1 | 2023 | 518 | 0.550 |
Why?
| | Skeleton | 1 | 2016 | 6 | 0.490 |
Why?
| | Osteogenesis | 6 | 2026 | 208 | 0.480 |
Why?
| | Fracture Healing | 4 | 2020 | 90 | 0.440 |
Why?
| | Bone Density | 5 | 2020 | 482 | 0.390 |
Why?
| | Stem Cells | 5 | 2026 | 626 | 0.390 |
Why?
| | Fractures, Bone | 2 | 2018 | 414 | 0.360 |
Why?
| | Femur | 4 | 2020 | 250 | 0.290 |
Why?
| | Signal Transduction | 6 | 2026 | 5226 | 0.230 |
Why?
| | Musculoskeletal Development | 1 | 2025 | 6 | 0.230 |
Why?
| | Endoribonucleases | 1 | 2026 | 80 | 0.230 |
Why?
| | Osteoclasts | 3 | 2019 | 52 | 0.230 |
Why?
| | Vincristine | 1 | 2025 | 140 | 0.220 |
Why?
| | Collagen Type I | 4 | 2010 | 147 | 0.220 |
Why?
| | Y Chromosome | 1 | 2024 | 36 | 0.220 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2025 | 177 | 0.210 |
Why?
| | Cachexia | 1 | 2025 | 75 | 0.210 |
Why?
| | beta Catenin | 1 | 2026 | 252 | 0.210 |
Why?
| | Mice | 24 | 2026 | 18339 | 0.200 |
Why?
| | Cell Differentiation | 7 | 2026 | 2050 | 0.190 |
Why?
| | Mice, Transgenic | 9 | 2019 | 2182 | 0.190 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2023 | 120 | 0.180 |
Why?
| | Transforming Growth Factor beta | 3 | 2016 | 479 | 0.180 |
Why?
| | Animals | 28 | 2026 | 38058 | 0.170 |
Why?
| | Endoplasmic Reticulum | 1 | 2023 | 266 | 0.170 |
Why?
| | Menisci, Tibial | 1 | 2021 | 78 | 0.160 |
Why?
| | Head and Neck Neoplasms | 1 | 2025 | 558 | 0.160 |
Why?
| | Growth Differentiation Factor 5 | 1 | 2019 | 3 | 0.160 |
Why?
| | Receptor, Notch1 | 1 | 2020 | 64 | 0.150 |
Why?
| | Knee Injuries | 1 | 2021 | 122 | 0.150 |
Why?
| | Interleukin-7 | 2 | 2012 | 65 | 0.150 |
Why?
| | Bone Resorption | 1 | 2019 | 80 | 0.150 |
Why?
| | Actins | 2 | 2014 | 425 | 0.140 |
Why?
| | Bone Morphogenetic Protein 2 | 3 | 2016 | 77 | 0.140 |
Why?
| | Muscle, Skeletal | 2 | 2025 | 1795 | 0.140 |
Why?
| | Tendons | 1 | 2019 | 129 | 0.140 |
Why?
| | X-Ray Microtomography | 4 | 2025 | 107 | 0.140 |
Why?
| | Osteoarthritis | 1 | 2021 | 196 | 0.140 |
Why?
| | Mitochondria | 1 | 2024 | 984 | 0.130 |
Why?
| | Spine | 2 | 2018 | 182 | 0.130 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 1 | 2019 | 192 | 0.130 |
Why?
| | Cartilage, Articular | 1 | 2021 | 343 | 0.130 |
Why?
| | Ovariectomy | 2 | 2006 | 162 | 0.120 |
Why?
| | Chitosan | 1 | 2016 | 38 | 0.120 |
Why?
| | Osteonectin | 1 | 2015 | 4 | 0.110 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2016 | 59 | 0.110 |
Why?
| | Osteocalcin | 3 | 2010 | 38 | 0.110 |
Why?
| | Chromosome Mapping | 1 | 2016 | 510 | 0.110 |
Why?
| | Bone Development | 1 | 2015 | 52 | 0.110 |
Why?
| | Muscular Atrophy | 2 | 2025 | 89 | 0.110 |
Why?
| | Fracture Fixation, Intramedullary | 1 | 2015 | 60 | 0.110 |
Why?
| | Skull | 1 | 2016 | 158 | 0.110 |
Why?
| | 3' Untranslated Regions | 1 | 2015 | 152 | 0.110 |
Why?
| | Organ Size | 1 | 2015 | 463 | 0.100 |
Why?
| | Cell Tracking | 1 | 2014 | 19 | 0.100 |
Why?
| | Green Fluorescent Proteins | 3 | 2016 | 405 | 0.100 |
Why?
| | Tissue Scaffolds | 1 | 2016 | 223 | 0.100 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2005 | 142 | 0.100 |
Why?
| | Receptors, Notch | 1 | 2014 | 92 | 0.100 |
Why?
| | Glucocorticoids | 2 | 2010 | 535 | 0.100 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2005 | 269 | 0.100 |
Why?
| | Genes, Reporter | 2 | 2015 | 275 | 0.090 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4557 | 0.090 |
Why?
| | Phenotype | 4 | 2018 | 3162 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2018 | 2145 | 0.090 |
Why?
| | Mice, Knockout | 6 | 2018 | 3121 | 0.080 |
Why?
| | Calcification, Physiologic | 3 | 2005 | 29 | 0.080 |
Why?
| | Parathyroid Hormone | 1 | 2011 | 112 | 0.080 |
Why?
| | Hydroxysteroid Dehydrogenases | 1 | 2010 | 2 | 0.080 |
Why?
| | Hyperlipidemias | 1 | 2011 | 122 | 0.080 |
Why?
| | Bone Marrow Cells | 4 | 2019 | 320 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2363 | 0.080 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5992 | 0.080 |
Why?
| | Hyponatremia | 1 | 2010 | 43 | 0.080 |
Why?
| | Rats | 5 | 2024 | 5597 | 0.070 |
Why?
| | Adipocytes | 2 | 2008 | 223 | 0.070 |
Why?
| | Hydrogels | 1 | 2016 | 700 | 0.070 |
Why?
| | MicroRNAs | 1 | 2015 | 701 | 0.070 |
Why?
| | Cyclooxygenase 2 | 2 | 2005 | 165 | 0.070 |
Why?
| | Lipid Metabolism | 1 | 2011 | 527 | 0.070 |
Why?
| | Marfan Syndrome | 1 | 2007 | 46 | 0.060 |
Why?
| | Activating Transcription Factor 6 | 1 | 2026 | 21 | 0.060 |
Why?
| | Genotype | 2 | 2024 | 1833 | 0.060 |
Why?
| | eIF-2 Kinase | 1 | 2026 | 29 | 0.060 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2008 | 266 | 0.060 |
Why?
| | Cell Proliferation | 3 | 2026 | 2496 | 0.060 |
Why?
| | Male | 12 | 2025 | 72315 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2012 | 2608 | 0.060 |
Why?
| | Female | 14 | 2025 | 78271 | 0.060 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 45 | 0.060 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2025 | 15 | 0.060 |
Why?
| | Tripartite Motif Proteins | 1 | 2025 | 40 | 0.060 |
Why?
| | Aging | 1 | 2016 | 1966 | 0.060 |
Why?
| | Genome-Wide Association Study | 2 | 2024 | 1406 | 0.060 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2004 | 33 | 0.050 |
Why?
| | Promoter Regions, Genetic | 2 | 2010 | 1257 | 0.050 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2003 | 10 | 0.050 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2025 | 214 | 0.050 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2025 | 192 | 0.050 |
Why?
| | Muscle Proteins | 1 | 2025 | 244 | 0.050 |
Why?
| | Corticosterone | 1 | 2003 | 244 | 0.050 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 74 | 0.050 |
Why?
| | Isoenzymes | 1 | 2002 | 299 | 0.040 |
Why?
| | Computers | 1 | 2020 | 67 | 0.040 |
Why?
| | Macrophage Colony-Stimulating Factor | 1 | 2019 | 19 | 0.040 |
Why?
| | RANK Ligand | 1 | 2019 | 26 | 0.040 |
Why?
| | RNA, Messenger | 5 | 2007 | 2832 | 0.040 |
Why?
| | Epiphyses | 1 | 2019 | 25 | 0.040 |
Why?
| | Humans | 9 | 2025 | 144759 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2002 | 442 | 0.040 |
Why?
| | Integrases | 1 | 2019 | 122 | 0.040 |
Why?
| | Gene Expression | 1 | 2003 | 1490 | 0.040 |
Why?
| | Information Management | 1 | 2018 | 16 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2006 | 1982 | 0.030 |
Why?
| | Tibia | 2 | 2011 | 176 | 0.030 |
Why?
| | Bone Marrow | 1 | 2019 | 304 | 0.030 |
Why?
| | Cell Death | 1 | 2019 | 383 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3540 | 0.030 |
Why?
| | Sex Characteristics | 2 | 2018 | 790 | 0.030 |
Why?
| | Knee Joint | 1 | 2021 | 426 | 0.030 |
Why?
| | Integrin-Binding Sialoprotein | 2 | 2007 | 6 | 0.030 |
Why?
| | Sialoglycoproteins | 2 | 2007 | 158 | 0.030 |
Why?
| | Bone Regeneration | 1 | 2016 | 28 | 0.030 |
Why?
| | Program Development | 1 | 2018 | 370 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2012 | 1173 | 0.030 |
Why?
| | Tibial Fractures | 1 | 2015 | 72 | 0.030 |
Why?
| | Blotting, Northern | 2 | 2004 | 204 | 0.030 |
Why?
| | Transcription Factors | 1 | 2002 | 1741 | 0.030 |
Why?
| | Staining and Labeling | 1 | 2014 | 151 | 0.020 |
Why?
| | Haplotypes | 1 | 2015 | 490 | 0.020 |
Why?
| | Disease Progression | 1 | 2021 | 2847 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2016 | 1370 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3409 | 0.020 |
Why?
| | Lymphopoiesis | 1 | 2012 | 27 | 0.020 |
Why?
| | Drug Delivery Systems | 1 | 2016 | 380 | 0.020 |
Why?
| | Adipose Tissue | 2 | 2008 | 652 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1486 | 0.020 |
Why?
| | Receptors, LDL | 1 | 2011 | 53 | 0.020 |
Why?
| | Apolipoprotein A-I | 1 | 2011 | 39 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2010 | 4154 | 0.020 |
Why?
| | Growth Plate | 1 | 2011 | 39 | 0.020 |
Why?
| | Mice, Inbred SENCAR | 1 | 2010 | 2 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2010 | 117 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 851 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2925 | 0.020 |
Why?
| | Dietary Fats | 1 | 2011 | 314 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 1054 | 0.020 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2011 | 319 | 0.020 |
Why?
| | Models, Animal | 1 | 2010 | 392 | 0.020 |
Why?
| | Protein Binding | 2 | 2005 | 2273 | 0.020 |
Why?
| | Ataxins | 1 | 2008 | 5 | 0.020 |
Why?
| | Ataxin-1 | 1 | 2008 | 5 | 0.020 |
Why?
| | Chondrocytes | 1 | 2010 | 232 | 0.020 |
Why?
| | Leukocyte Common Antigens | 1 | 2008 | 88 | 0.020 |
Why?
| | Skin Abnormalities | 1 | 2007 | 12 | 0.020 |
Why?
| | Chromosomes, Mammalian | 1 | 2007 | 28 | 0.020 |
Why?
| | Histocytochemistry | 1 | 2007 | 79 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2007 | 124 | 0.020 |
Why?
| | Gene Duplication | 1 | 2007 | 67 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2011 | 1087 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 299 | 0.020 |
Why?
| | Stromal Cells | 1 | 2007 | 124 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2007 | 145 | 0.020 |
Why?
| | Microfilament Proteins | 1 | 2007 | 135 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2010 | 699 | 0.020 |
Why?
| | Sex Factors | 1 | 2012 | 2112 | 0.010 |
Why?
| | Cell Movement | 1 | 2010 | 965 | 0.010 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2005 | 19 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2730 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2006 | 205 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2005 | 193 | 0.010 |
Why?
| | Absorptiometry, Photon | 1 | 2006 | 276 | 0.010 |
Why?
| | Time Factors | 2 | 2007 | 7173 | 0.010 |
Why?
| | Genes, Dominant | 1 | 2004 | 101 | 0.010 |
Why?
| | Mice, Nude | 1 | 2006 | 682 | 0.010 |
Why?
| | Lymphocytes | 1 | 2006 | 382 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 2008 | 592 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2010 | 2527 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2004 | 327 | 0.010 |
Why?
| | Transgenes | 1 | 2004 | 189 | 0.010 |
Why?
| | Tritium | 1 | 2003 | 68 | 0.010 |
Why?
| | Introns | 1 | 2004 | 254 | 0.010 |
Why?
| | Organ Culture Techniques | 1 | 2003 | 154 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2004 | 402 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2008 | 748 | 0.010 |
Why?
| | Core Binding Factors | 1 | 2002 | 2 | 0.010 |
Why?
| | Cell Lineage | 1 | 2004 | 376 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 983 | 0.010 |
Why?
| | Enzyme Induction | 1 | 2002 | 88 | 0.010 |
Why?
| | Transfection | 1 | 2004 | 940 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2002 | 156 | 0.010 |
Why?
| | Luciferases | 1 | 2002 | 152 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2002 | 87 | 0.010 |
Why?
| | Binding Sites | 1 | 2005 | 1329 | 0.010 |
Why?
| | Models, Genetic | 1 | 2004 | 536 | 0.010 |
Why?
| | Dinoprostone | 1 | 2002 | 178 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2004 | 458 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2002 | 381 | 0.010 |
Why?
| | Hydrocortisone | 1 | 2003 | 304 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2004 | 618 | 0.010 |
Why?
| | Collagen | 1 | 2003 | 456 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2002 | 1047 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1716 | 0.010 |
Why?
| | Body Weight | 1 | 2004 | 976 | 0.010 |
Why?
| | Skin | 1 | 2004 | 755 | 0.010 |
Why?
| | Aged | 1 | 2018 | 25913 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2004 | 1496 | 0.010 |
Why?
| | RNA | 1 | 2004 | 940 | 0.010 |
Why?
| | Middle Aged | 1 | 2018 | 35875 | 0.010 |
Why?
| | Mutation | 1 | 2007 | 4089 | 0.010 |
Why?
| | Adult | 1 | 2018 | 40449 | 0.010 |
Why?
| | Lung | 1 | 2004 | 4109 | 0.010 |
Why?
|
|
Adams's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|